http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104045704-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107 |
| filingDate | 2013-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104045704-B |
| titleOfInvention | PEGization recombined human IFN-λ 1, Preparation Method And The Use |
| abstract | The invention provides a kind of PEGization recombined human IFN λ 1, Preparation Method And The Use.Specifically, present invention achieves the PEG pointed decoration to recombined human IFN λ 1, present invention also offers the thus obtained PEGization recombined human IFN λ 1 purposes in the medicine of preparation treatment chronic hepatitis B or hepatocarcinoma.The homogeneity of prepared according to the methods of the invention PEGization recombined human IFN λ 1 is good, and purity is more than 98%.PEGization recombined human IFN λ 1 can significantly inhibit the growth of tumor bearing nude mice Subcutaneous tumor, significantly reduces HBsAg content in nude mouse serum, shows preferable safety simultaneously. |
| priorityDate | 2013-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.